Biotech
May 22, 2012 at 10:15 | Source: Moneycontrol.com
May 16, 2012 at 08:31 | Source: Moneycontrol.com
May 15, 2012 at 14:24 | Source: Moneycontrol.com
May 11, 2012 at 18:08 | Source: Moneycontrol.com
May 02, 2012 at 12:32 | Source: PTI
News across the web »
May 28, 2012 at 00:21 | Source: The Hindu BusinessLine
May 27, 2012 at 20:51 | Source: Forbes
May 27, 2012 at 20:51 | Source: The Hindu BusinessLine
May 26, 2012 at 18:07 | Source: The Hindu BusinessLine
May 25, 2012 at 21:37 | Source: Market Watch
Interact & exchange stock tips & market info »
At 11:52 hrs Saamya Biotech has formed a strong bullish bar re...
about 3 hrs 27 min 36 sec ago
At 10:43 hrs Chemcel Biotech has formed a gap down chart patter...
about 4 hrs 27 min 24 sec ago
Related News »
Ten years ago, Arizona committed to an aggressive Biotech Roadmap to make the state into a biotech hub. Sometimes it is difficult for the community and for me, from the outside, to see what has happened in the past decade, so I thought I had better go to ...
May 22, 2012 at 17:04 | Source: Phoenix Business Journal
Biotech entrepreneur Jeff Morhet drew notice in the tight-knit metro Phoenix biotechnology community for heading a small publicly traded pharmaceutical company, starting a biotech group and helping to launch a city-funded technology incubator in Chandler.
May 26, 2012 at 21:53 | Source: AZCentral.com
CINCINNATI, OH and HANNOVER, GERMANY and BOTHELL, WA — Marina Biotech, Inc. (OTCQX: MRNA), a leading nucleic acid-based drug discovery and development company, and Girindus Group today announced that they have entered into a strategic ...
May 21, 2012 at 10:25 | Source: msnbc.com
Strong prospects for new drug approvals, a favorable M&A environment, and a positive fundamental outlook have the biotechnology industry looking healthy, according to S&P Capital IQ. Investors who want exposure to the overall sector should consider ...
May 16, 2012 at 16:57 | Source: Seekingalpha.com
Lifted by new drug approvals along with increased mergers and acquisitions activity and a churning rumor mill to that effect, biotechnology stocks have been stellar performers in 2012. Earlier this month, S&P Capital IQ cited those catalysts as ...
May 21, 2012 at 18:17 | Source: Marketwatch
NEW YORK, NY--(Marketwire -05/09/12)- In recent months the Biotech Industry has become a hotbed of Merger and Acquisition (M&A) activity and speculation. As large pharmaceuticals face major patent expirations in 2012 they have looked to biotech ...
May 26, 2012 at 22:07 | Source: Yahoo Finance
The chart below shows the one year price performance of XBI, versus its 200 day moving average: Looking at the chart above, XBI’s low point in its 52 week range is $54.71 per share, with $83.37 as the 52 week high point — that compares with ...
May 25, 2012 at 18:12 | Source: Forbes
GlaxoSmithKline ($GSK) has shown in a series of M&A and investment moves that the London-based drug giant prefers to bet on known commodities--existing biotech partners. Bloomberg analyzed GSK's strategy and speculates that the company could ...
May 25, 2012 at 14:52 | Source: FierceBiotech
"Biotech stocks can provide sudden and magnificent returns, but they can be just as unforgiving. How can you decide which biotech stocks are worth investing in then? We looked into it further: We ran a screen of biotech stocks that are showing ...
May 24, 2012 at 15:00 | Source: Minyanville
Innovations in biotechnology are evolving at the speed of light. In fact, astonishing advancements in biotech have transformed the way we practice medicine. Leading-edge biotech products and breakthroughs are literally saving thousands of lives ...
May 16, 2012 at 12:47 | Source: Money Morning